Loading…
Loading…
6934.TWO (Hcmed) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

| 7729.TWO | Steminent Biotherapeutics Inc. | NT$78.90 | NT$5.8B |
| 1762.TW | Chunghwa Chemical Synthesis & Biotech Co., Ltd. | NT$35.95 | NT$2.8B |
| 4168.TWO | GlycoNex Incorporation | NT$22.75 | NT$2.6B |
| 4195.TWO | Genomics BioSci & Tech. Co.,Ltd. | NT$29.45 | NT$2.4B |
| 6676.TWO | Sunny Pharmtech Inc. | NT$12.35 | NT$2.1B |
| 6704.TWO | Gwo Xi Stem Cell Applied Technology Co. , Ltd | NT$19.20 | NT$1.8B |
| 6709.TWO | Advagene Biopharma Co., Ltd. | NT$25.85 | NT$1.8B |
| 6846.TWO | Greenyn Biotechnology Co., Ltd | NT$57.70 | NT$1.6B |
| 6864.TWO | Anti-Microbial Savior BioteQ Co., Ltd | NT$40.50 | NT$1.5B |
| 6580.TWO | TaiRx, Inc. | NT$12.30 | NT$1.4B |